论文部分内容阅读
目的探讨分析胺碘酮在快速性心律失常上的临床治疗效果。方法从2016年1月至2016年10月,选取我院100例快速性心律失常的患者进行回顾性分析,用随机数据表法将其分为观察组和对照组两组,分别采用胺碘酮联合美托洛尔治疗与单纯采用胺碘酮治疗,分析对比两组患者的临床疗效及治疗前后各项相关因素变化情况分析。结果观察组显著好转与好转患者与对照组相比无明显差异(均P>0.05),但其有效率92.00%(46/50)明显显著高于对照组患者的76.00%(38/50),且观察组无好转患者占比8.00%(4/50)显著低于对照组患者的24.00%(12/50),差异有统计学意义(P<0.05);两组患者治疗前心率、收缩压及舒张压均无明显差异(P>0.05),两组患者手术前后的心率、收缩压及舒张压观察组等各项相关因素均明显降低(P<0.05),且观察组患者治疗后的心率、收缩压及舒张压均明显低于对照组,差异有统计学意义(P<0.05)。结论胺碘酮联合美托洛尔相较于单纯胺碘酮效果更加显著,并且能够显著改善快速性心律失常患者的心率、舒张压及收缩压等相关指标,在快速性心律失常的临床治疗中占有举足轻重的地位,且具有非常高的临床发展价值。
Objective To investigate the clinical effect of amiodarone on tachyarrhythmia. Methods From January 2016 to October 2016, 100 patients with tachyarrhythmia in our hospital were retrospectively analyzed. They were divided into observation group and control group by random number table method. Amiodarone Metoprolol combined with simple treatment with amiodarone, analysis and comparison of two groups of patients with clinical efficacy and changes in the treatment of various factors before and after analysis. Results There was no significant difference between the observation group and the control group (all P> 0.05), but the effective rate was 92.00% (46/50) significantly higher than that of the control group (76.00%, 38/50) (8.00%, 4/50) in the observation group was significantly lower than that in the control group (24.00%, 12/50), the difference was statistically significant (P <0.05); before treatment, heart rate, systolic blood pressure (P> 0.05). The related factors such as heart rate, systolic blood pressure and diastolic blood pressure observation group before and after operation in both groups were significantly lower (P <0.05), and the heart rate after treatment in the observation group , Systolic blood pressure and diastolic blood pressure were significantly lower than the control group, the difference was statistically significant (P <0.05). Conclusions Amiodarone combined with metoprolol is more effective than simple amiodarone, and can significantly improve the heart rate, diastolic blood pressure and systolic blood pressure in patients with tachyarrhythmia and other related indicators in the clinical treatment of tachyarrhythmia Occupies a pivotal position, and has a very high clinical development value.